The FDA said Walgreens has addressed violations related to drug listing deficiencies for one of its products, according to a Dec. 19 close-out letter. The agency previously cited Walgreens in ...
The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...
A package of Wegovy by Novo Nordisk sits on a table in Copenhagen, Denmark, in 2023. The FDA is cracking down on ingredients from potentially dangerous active ingredients used in GLP-1 drugs that also ...
On Sept. 5, the FDA announced an import alert and green list for glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredient (API) manufacturers. The FDA included manufacturers on the green list ...
The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular weight-loss drugs like Ozempic and Zepbound.
Patients are advised to get a prescription from their doctor and to fill the prescription at a licensed pharmacy or use the FDA's BeSafeRx campaign to determine where to safely buy medications online.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results